secwatch.observer — SEC 8-K summary
======================================

Issuer:     SAFEGUARD SCIENTIFICS INC (SFES)
CIK:        0000086115
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001437749-23-030023
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Safeguard Scientifics Q3 net income $0.9M, vs loss $3.2M; cash $15.7M
---------------------------------------------------------------------

- Q3 net income $0.9M ($0.06 diluted EPS) vs net loss $3.2M ($0.19 loss) in Q3 2022.
- 9M net loss narrowed to $5.4M ($0.33 loss) from $9.4M ($0.57 loss) year earlier.
- Cash and equivalents $15.7M; carrying value of ownership interests $14.8M (cost $122.8M).
- InfoBionic recap reduced ownership to ~5% with $1.7M non-cash gain; Trice Medical recap resulted in de minimis stake.
- Aggregate trailing 12-month revenue of six portfolio companies $96M, up 10.3% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/86115/000143774923030023/0001437749-23-030023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/86115/000143774923030023/sfe20231102_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-030023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer